Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.17 USD | +1.17% | +1.23% | +62.23% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.23% | 643M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.92% | 248B | |
-1.80% | 219B | |
+11.06% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Harrow Health's PT to $45 From $42 on Heels of Announced Transactions With Santen, Novaliq; Keeps Buy Rating